381 related articles for article (PubMed ID: 29897328)
1. Insights into the genome diversity and virulence of two clinical isolates of Burkholderia cenocepacia.
Salloum T; Nassour E; Araj GF; Abboud E; Tokajian S
J Med Microbiol; 2018 Aug; 67(8):1157-1167. PubMed ID: 29897328
[TBL] [Abstract][Full Text] [Related]
2. Genomic analysis of Burkholderia cenocepacia isolated from a liver abscess in a patient with cystic fibrosis.
de Freitas Vianna E; Menezes NIM; de Almeida MM; de Freitas FAD; da Costa Ferreira Leite C; Firmida MC; de Medeiros DRI; Souza Leão R; Mattos Albano R; Andrade Marques E
APMIS; 2021 Nov; 129(11):631-640. PubMed ID: 34561922
[TBL] [Abstract][Full Text] [Related]
3. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.
Drevinek P; Mahenthiralingam E
Clin Microbiol Infect; 2010 Jul; 16(7):821-30. PubMed ID: 20880411
[TBL] [Abstract][Full Text] [Related]
4. Genomic features, antimicrobial susceptibility, and epidemiological insights into
Saroha T; Patil PP; Rana R; Kumar R; Kumar S; Singhal L; Gautam V; Patil PB
Front Cell Infect Microbiol; 2023; 13():1151594. PubMed ID: 37153161
[TBL] [Abstract][Full Text] [Related]
5. Whole-Genome Sequencing of Three Clonal Clinical Isolates of B. cenocepacia from a Patient with Cystic Fibrosis.
Miller RR; Hird TJ; Tang P; Zlosnik JE
PLoS One; 2015; 10(11):e0143472. PubMed ID: 26599356
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of the Burkholderia cenocepacia K56-2 essential genome reveals cell envelope functions that are uniquely required for survival in species of the genus Burkholderia.
Gislason AS; Turner K; Domaratzki M; Cardona ST
Microb Genom; 2017 Nov; 3(11):. PubMed ID: 29208119
[TBL] [Abstract][Full Text] [Related]
7. The Burkholderia cenocepacia Type VI Secretion System Effector TecA Is a Virulence Factor in Mouse Models of Lung Infection.
Loeven NA; Perault AI; Cotter PA; Hodges CA; Schwartzman JD; Hampton TH; Bliska JB
mBio; 2021 Oct; 12(5):e0209821. PubMed ID: 34579569
[TBL] [Abstract][Full Text] [Related]
8. Burkholderia cenocepacia, B. multivorans, B. ambifaria and B. vietnamiensis isolates from cystic fibrosis patients have different profiles of exoenzyme production.
Carvalho AP; Ventura GM; Pereira CB; Leão RS; Folescu TW; Higa L; Teixeira LM; Plotkowski MC; Merquior VL; Albano RM; Marques EA
APMIS; 2007 Apr; 115(4):311-8. PubMed ID: 17504297
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis.
Sass A; Marchbank A; Tullis E; Lipuma JJ; Mahenthiralingam E
BMC Genomics; 2011 Jul; 12():373. PubMed ID: 21781329
[TBL] [Abstract][Full Text] [Related]
10. Molecular approaches to pathogenesis study of Burkholderia cenocepacia, an important cystic fibrosis opportunistic bacterium.
Bazzini S; Udine C; Riccardi G
Appl Microbiol Biotechnol; 2011 Dec; 92(5):887-95. PubMed ID: 21997606
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center.
Manno G; Dalmastri C; Tabacchioni S; Vandamme P; Lorini R; Minicucci L; Romano L; Giannattasio A; Chiarini L; Bevivino A
J Clin Microbiol; 2004 Apr; 42(4):1491-7. PubMed ID: 15070994
[TBL] [Abstract][Full Text] [Related]
12. Diversity of the parB and repA genes of the Burkholderia cepacia complex and their utility for rapid identification of Burkholderia cenocepacia.
Drevinek P; Baldwin A; Dowson CG; Mahenthiralingam E
BMC Microbiol; 2008 Mar; 8():44. PubMed ID: 18328098
[TBL] [Abstract][Full Text] [Related]
13. Identification and analysis of genomic islands in Burkholderia cenocepacia AU 1054 with emphasis on pathogenicity islands.
Guo FB; Xiong L; Zhang KY; Dong C; Zhang FZ; Woo PC
BMC Microbiol; 2017 Mar; 17(1):73. PubMed ID: 28347342
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide analysis of DNA repeats in Burkholderia cenocepacia J2315 identifies a novel adhesin-like gene unique to epidemic-associated strains of the ET-12 lineage.
Mil-Homens D; Rocha EPC; Fialho AM
Microbiology (Reading); 2010 Apr; 156(Pt 4):1084-1096. PubMed ID: 20019083
[TBL] [Abstract][Full Text] [Related]
15. The temperate Burkholderia phage AP3 of the Peduovirinae shows efficient antimicrobial activity against B. cenocepacia of the IIIA lineage.
Roszniowski B; Latka A; Maciejewska B; Vandenheuvel D; Olszak T; Briers Y; Holt GS; Valvano MA; Lavigne R; Smith DL; Drulis-Kawa Z
Appl Microbiol Biotechnol; 2017 Feb; 101(3):1203-1216. PubMed ID: 27770178
[TBL] [Abstract][Full Text] [Related]
16. Exploring the metabolic network of the epidemic pathogen Burkholderia cenocepacia J2315 via genome-scale reconstruction.
Fang K; Zhao H; Sun C; Lam CM; Chang S; Zhang K; Panda G; Godinho M; Martins dos Santos VA; Wang J
BMC Syst Biol; 2011 May; 5():83. PubMed ID: 21609491
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic diversity and genotypic flexibility of
Lee AH; Flibotte S; Sinha S; Paiero A; Ehrlich RL; Balashov S; Ehrlich GD; Zlosnik JE; Mell JC; Nislow C
Genome Res; 2017 Apr; 27(4):650-662. PubMed ID: 28325850
[TBL] [Abstract][Full Text] [Related]
18. Reconstitution of O-specific lipopolysaccharide expression in Burkholderia cenocepacia strain J2315, which is associated with transmissible infections in patients with cystic fibrosis.
Ortega X; Hunt TA; Loutet S; Vinion-Dubiel AD; Datta A; Choudhury B; Goldberg JB; Carlson R; Valvano MA
J Bacteriol; 2005 Feb; 187(4):1324-33. PubMed ID: 15687196
[TBL] [Abstract][Full Text] [Related]
19. A novel method for investigating Burkholderia cenocepacia infections in patients with cystic fibrosis and other chronic diseases of the airways.
Wijers CD; Vagedes R; Weingart C
BMC Microbiol; 2016 Sep; 16(1):200. PubMed ID: 27586172
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of bacteraemia caused by Burkholderia cepacia complex species and antimicrobial susceptibility of the isolates in a medical centre in Taiwan.
Chien YC; Liao CH; Sheng WH; Chien JY; Huang YT; Yu CJ; Hsueh PR
Int J Antimicrob Agents; 2018 Mar; 51(3):357-364. PubMed ID: 28705667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
